biotech2 min read
Biomatter lands $18M to speed up enzyme development with AI
Biomatter, a company specialising in customenzyme design, has raised $18 million in an oversubscribed Series A fundinground led by Astanor, with participation from existing investors UVC Partners,Inve...
By Tamara DjurickovicTech.eu

Read the full story
Originally published by Tech.eu on Nov 12, 2026.
Comments
Sign in to join the discussion.